Physician profile
Richard Smith
NPI 1033213749
$7,703.12
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,143 · 2020: $174 · 2021: $294 · 2022: $75.80 · 2023: $16.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,410.00 | 2019 | |
| Spinal Elements, INC. | $744.11 | 2019 | |
| Reel Surgical, INC. | $531.50 | 2019 | |
| Amgen INC. | $233.48 | 2019-2022 | |
| Surgalign Spine Technologies, INC. | $125.06 | 2019 | |
| Si-Bone, INC. | $101.05 | 2019 | |
| Medtronic USA, INC. | $90.83 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.93 | 2019-2021 | |
| Nevro Corp. | $61.97 | 2020-2022 | |
| Abbott Laboratories | $53.01 | 2020-2021 | |
| Pacira Therapeutics, INC. | $45.10 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $31.53 | 2019 | |
| Encore Medical, LP | $30.87 | 2020-2021 | |
| Boston Scientific Corporation | $26.32 | 2019-2021 | |
| Bioventus LLC | $22.57 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $22.38 | 2020 | |
| Zimmer Biomet Holdings, INC. | $21.05 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.04 | 2021 | |
| Depuy Synthes Sales INC. | $16.28 | 2023 | Orthovisc |
| Shionogi INC | $15.46 | 2019 | |
| Pfizer INC. | $15.14 | 2019 | |
| Eisai INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.